載入...
Dual‐Specificity Phosphatase 9 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through ASK1 Suppression
Nonalcoholic fatty liver disease (NAFLD), ranging from nonalcoholic fatty liver to nonalcoholic steatohepatitis (NASH), is the leading cause of chronic liver diseases. Until now, no medications for NAFLD have been approved by relevant governmental agencies. Dual‐specificity phosphatase 9 (Dusp9) is...
Na minha lista:
| 發表在: | Hepatology |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6590435/ https://ncbi.nlm.nih.gov/pubmed/30063256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.30198 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|